Third ventriculostomy
Third Ventriculostomy is a neurosurgical procedure used for the treatment of hydrocephalus, a condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the cavities (ventricles) of the brain. This procedure creates an opening in the floor of the third ventricle, allowing CSF to bypass the obstructed pathways and flow directly towards the sites of absorption around the brain and spinal cord, thus relieving pressure.
Indications[edit | edit source]
Third Ventriculostomy is primarily indicated in cases of obstructive or non-communicating hydrocephalus, where the flow of CSF is blocked along one or more of the narrow passages connecting the ventricles. It is most commonly recommended for patients with a blockage in the aqueduct of Sylvius, the channel that connects the third and fourth ventricles.
Procedure[edit | edit source]
Performed under general anesthesia, the procedure involves the use of an endoscope, a thin, flexible tube with a camera and light at the end, allowing the surgeon to visualize the ventricular system. A small hole is drilled in the skull, and the endoscope is guided into the third ventricle. The surgeon then creates an opening in the floor of the third ventricle, allowing CSF to escape into the basal cisterns, where it can be absorbed.
Risks and Complications[edit | edit source]
As with any surgical procedure, third ventriculostomy carries risks, including infection, bleeding, and damage to surrounding brain tissue. There is also a risk that the new opening may close, necessitating further surgery. However, for many patients, third ventriculostomy provides a viable alternative to ventriculoperitoneal shunt placement, which involves implanting a mechanical device and carries a higher risk of infection and malfunction.
Outcomes[edit | edit source]
The success of third ventriculostomy depends on various factors, including the patient's age, the cause of hydrocephalus, and the presence of any underlying brain conditions. In general, younger patients with a clear obstruction in the aqueduct of Sylvius tend to have better outcomes. Long-term follow-up is necessary to monitor for potential closure of the ventriculostomy site and the need for additional treatment.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
